Table 2.
Model 1 | Model 2 | Model 3 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | ||
All-cause mortality | ||||||||||
Q1(2.03–2.54) | 1(Ref) | 1(Ref) | 1(Ref) | |||||||
Q2(2.82–3.11) | 0.87 | 0.83, 0.92 | <0.001 | 0.97 | 0.92, 1.02 | 0.214 | 0.96 | 0.92, 1.01 | 0.158 | |
Q3(3.36–3.67) | 0.79 | 0.75, 0.84 | <0.001 | 0.91 | 0.86, 0.96 | <0.001 | 0.91 | 0.86, 0.96 | <0.001 | |
Q4(4.09–4.91) | 0.87 | 0.83, 0.92 | <0.001 | 0.95 | 0.90, 0.99 | 0.036 | 0.95 | 0.89, 0.99 | 0.039 | |
Ptrend | <0.001 | 0.008 | 0.010 | |||||||
Low-stable | 1(Ref) | 1(Ref) | 1(Ref) | |||||||
Moderate-stable | 1.17 | 1.12, 1.23 | <0.001 | 1.18 | 1.13, 1.23 | <0.001 | 1.18 | 1.13, 1.24 | <0.001 | |
High-stable | 2.09 | 1.99, 2.19 | <0.001 | 1.74 | 1.66, 1.82 | <0.001 | 1.74 | 1.66, 1.82 | <0.001 | |
CVD mortality | ||||||||||
Q1(2.03–2.54) | 1(Ref) | 1(Ref) | 1(Ref) | |||||||
Q2(2.82–3.11) | 0.83 | 0.77, 0.89 | <0.001 | 0.92 | 0.86, 0.99 | 0.027 | 0.92 | 0.86, 0.98 | 0.018 | |
Q3(3.36–3.67) | 0.81 | 0.76, 0.87 | <0.001 | 0.93 | 0.87, 1.01 | 0.056 | 0.93 | 0.87, 0.99 | 0.043 | |
Q4(4.09–4.91) | 0.91 | 0.84, 0.97 | 0.006 | 0.98 | 0.91, 1.05 | 0.597 | 0.98 | 0.91, 1.05 | 0.532 | |
Ptrend | 0.009 | 0.675 | 0.617 | |||||||
Low-stable | 1(Ref) | 1(Ref) | 1(Ref) | |||||||
Moderate-stable | 1.09 | 1.03, 1.16 | 0.004 | 1.11 | 1.05, 1.18 | <0.001 | 1.12 | 1.05, 1.18 | <0.001 | |
High-stable | 1.94 | 1.82, 2.07 | <0.001 | 1.64 | 1.53, 1.75 | <0.001 | 1.64 | 1.53, 1.75 | <0.001 |
Data were showed by HR, 95% CI and P value. Model 1: Unadjusted. Model 2: Adjusted for age and gender. Model 3: Adjusted for age, gender, smoking, alcohol consumption, and physical activity. Q1: 1st Quartiles; Q2: 2nd Quartiles; Q3: 3rd Quartiles; Q4: 4th Quartiles. Q1 to Q4 are the quartiles of BRI at baseline.